NCT01104493 - A Clinical Study to Assess the Safety of a New Influenza Vaccine | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

December 31, 2010

Conditions

Healthy

Interventions

BIOLOGICAL

Monovalent Frozen FluMist®

Single dose of monovalent vaccine (240 subjects) by intranasal spray on Study Day 1.

OTHER

Placebo

Single dose of placebo (60 subjects) by intranasal spray on Study Day 1

Trial Locations (3)

Clinical Research Atlanta, Stockbridge

Miami Research Associates, South Miami

Columbia Research Group, Inc, Portland